Lack of IKBA coding region mutations in primary mediastinal large B-cell lymphoma and the host response subtype of diffuse large B-cell lymphoma [5]

Blood

Volumn 107, Issue 2, 2006, Pages 844-845

  Takahashi, Hidenobu ^a   Feuerhake, Friedrich ^a   Monti, Stefano ^a   Kutok, Jeffery L ^a   Aster, Jon C ^a   Shipp, Margaret A ^a  

^a DANA FARBER CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

I KAPPA B ALPHA;

B CELL LYMPHOMA; GENETIC ANALYSIS; GENETIC CODE; HUMAN; IMMUNE RESPONSE; LARGE CELL LYMPHOMA; LETTER; MUTATION; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SINGLE NUCLEOTIDE POLYMORPHISM; STATISTICAL SIGNIFICANCE;

EID: 30444435983     PISSN: 00064971     EISSN: 00064971     Source Type: Journal    
DOI: 10.1182/blood-2005-07-2827     Document Type: Letter

References (10)

1. Savage K, Monti S, Kutok J, et al. The molecular signature of mediastinal large B-cell lymphoma differs from that of other diffuse large B-cell lymphomas and shares features with classical Hodgkin lymphoma. Blood. 2003;102:3871-3879.
2. Monti S, Savage KJ, Kutok JL, et al. Molecular profiling of diffuse large B-cell lymphoma identifies robust subtypes including one characterized by host inflammatory response. Blood. 2005;105:1851-1861.
3. Rosenwald A, Wright G, Leroy K, et al. Molecular diagnosis of primary mediastinal B cell lymphoma identifies a clinically favorable subgroup of diffuse large B cell lymphoma related to Hodgkin lymphoma. J Exp Med. 2003;198:851-862.
4. Feuerhake F, Kutok J, Monti S, et al. NFκB activity, function, and target-gene signatures in primary mediastinal large B-cell lymphoma and diffuse large B-cell lymphoma subtypes. Blood. 2005;106:1392-1399.
5. Davis RE, Brown KD, Siebenlist U, Staudt LM. Constitutive nuclear factor kappaB activity is required for survival of activated B cell-like diffuse large B cell lymphoma cells. J Exp Med. 2001;194:1861-1874.
6. Cabannes E, Khan G, Aillet F, Jarrett RF, Hay RT. Mutations of the IκBα gene in Hodgkin's disease suggest a tumour suppressor role for IκBα. Oncogene. 1999;18:3063-3070.
7. Emmerich F, Meiser M, Hummel M, et al. Overexpression of I kappa alpha without inhibition of NF-κB activity and mutations in the I kappa B alpha gene in Reed-Sternberg cells. Blood. 1999;94:3129-3134.
8. Jungnickel B, Staratschek-Jox A, Brauninger A, et al. Clonal deleterious mutations in the IκBα gene in the malignant cells in Hodgkin's lymphoma. J Exp Med. 2000;191:395-401.
9. Thomas RK, Wickenhauser C, Tawadros S, et al. Mutational analysis of the IκB gene in activated B cell-like diffuse large B-cell lymphoma. Br J Haematol. 2004;126:50-54.
10. Haskill S, Beg AA, Tompkins SM, et al. Characterization of an immediate-early gene induced in adherent monocytes that encodes I kappa B-like activity. Cell. 1991;65:1281-1289.